Analgesic and immunomodulatory cannabinoids
US6939977B2 · kind B2 · utility
7Cited by
67References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2002 |
| Grant date | Sep 6, 2005 |
| Priority date | — |
| Expiry date | Dec 4, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds represented by the following structural formula:R-X-Y;and physiologically acceptable salts thereof. Also disclosed is a method of stimulating a CB1 and/or CB2 receptor in a subject. The method comprises administering to the subject a therapeutically effective amount of R-X-Y.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.